IPO Preview: Vital Therapies Seeking Alpha VTL's product candidate, the ELAD System, or ELAD, is a bio-artificial liver therapy that operates outside the body, or extracorporeal, and is designed to allow the patient's own liver to regenerate to a healthy state, or to stabilize the patient until ... IPO Report: Vital Therapies (VTL) |
